glp-1 drops fda approved Oral – BloomMD Scam weight-loss drops marketed to
Description
Struggling to access GLP-1s like Zepbound because of cost or lack of insurance coverage
Those with obesity might have other serious chronic health conditions, including diabetes and high blood pressure, which are leading risk factors for heart disease and stroke
Methods Adults with T2D treated with 2 glucose-lowering agents who initiated GLP-1 RAs or basal insulin from 2010 to 2019 were propensity-score matched (1:1) and followed until October 2021 (intention-to-treat [ITT])
More doable
Book a free consultation!
